Apollo Therapeutics
Jessica Calloway Jones is an experienced professional in the biopharmaceutical industry, currently serving as Program Lead and Director at Apollo Therapeutics since January 2025. Prior to this role, Jessica held various positions at Vertex Pharmaceuticals from February 2020 to December 2024, culminating as Principal Scientist and Team Leader. Jessica's career also includes a significant tenure at Pfizer from April 2005 to February 2020, progressing from Research Intern to Principal Scientist. Earlier experience includes a Research Associate I role at MPI Research and initial internship at Pfizer focused on Animal Health Discovery Biology. Jessica holds a Doctor of Philosophy in Biochemistry from Boston University School of Medicine and a Bachelor of Science in Biochemistry and Biomedical Sciences from Western Michigan University.
This person is not in any teams